Urinary IncontinencePELVICATHLENCT07644273
Effects of a Multimodal and Multidimensional Intervention on Urinary Incontinence in Young Nulliparous Female Athletes.
A study testing Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme. and Usual activities in people with Urinary Incontinence, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.
Trial summary
A prevalence of urinary incontinence ranging from 5.7% to 80% has been observed in young nulliparous athletes during their activity. The usual recommendations for managing adult women do not seem to be transferable. Read more about this study
- Who is it for?
- Ages 15 to 40 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Urinary Incontinence
- What is being tested?
- Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme. and Usual activities
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 198 participants
- Where
- 1 siteFrance
- Study dates
- 17 Sep 2026to Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 40 years
- Women only
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Female subject, nulliparous
- Member of an athletics club affiliated with the French Athletics Federation (FFA)
- At least 15 years old at the start of the study and belonging to the U16/U18/U20/U23 categories (born between January 1, 2005, and September 1, 2011)
- Having internet access
- Having access to a digital device (computer, tablet, mobile phone)
- Affiliated with or covered by a social security scheme
- Having freely given their express consent, as well as the express consent of both parents for minor participants
Who cannot join
- Any individual deprived of their liberty or subject to legal protection (guardianship, curatorship, or protective supervision).
- A pregnant woman, a woman who has been pregnant, or a woman planning a pregnancy within the last nine months.
- Any individual unable to understand the purpose and conditions of the study.
- Any individual unable to give their consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHU de Saint-Etienne
Saint-Etienne, 42055
Pascal EDOUARD, PHD, (0)477127985 ext. +33, pascal.edouard@univ-st-etienne.fr
Pascal EDOUARD, PHD
About this study
Official title: Effects of a Multimodal and Multidimensional Intervention on Urinary Incontinence in Young Nulliparous Female Athletes. Single-Center Randomized Controlled Stepped-Wedge Trial
A prevalence of urinary incontinence ranging from 5.7% to 80% has been observed in young nulliparous athletes during their activity.
The usual recommendations for managing adult women do not seem to be transferable.
Young nulliparous athletes need specific educational and behavioral interventions and an alternative to pelvic floor muscle strengthening.
A multimodal and multidimensional intervention for athletes and coaches combining specific pelvic health education and strengthening of lumbopelvic-abdominal stability appears to be an innovative and optimal solution for reducing the symptoms of urinary incontinence in young nulliparous women who participate in athletics.
- Conditions
- Urinary Incontinence
- Being tested
- Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme., Usual activities
- Keywords
- Urinary incontinence, women's health, track and field
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme.Other
The intervention will consist of participants:
- reviewing educational content (8 educational videos online) ii) participating in two in-person sessions at the athletics club and performing lumbar-pelvic-abdominal stability exercises iii) learning and implementing recommendations for empowering themselves in pelvic health management. iv) complete reports in 6 questionnaires during follow-up.
Usual activitiesOther
Collection of data on routine activities
| Study group | Role | What they receive |
|---|---|---|
| Control condition | Active comparator | Usual activities Receives: Other: Usual activities |
| Interventional condition | Experimental | Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening program. Receives: Other: Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Urinary incontinence symptoms
Severity of urinary incontinence symptoms as measured by the ICIQ-UI-SF score (International Consultation on Incontinence Questionnaire - Short Form for Urinary Incontinence). Scores typically range from 0 to 21. The higher the score, the more severe the urinary incontinence.
Measured: Week 1, 7, 13, 19, 25, 31
Secondary outcomes (13)
The program's effects on the prevalence of urinary incontinence
The program's effects on the prevalence of urinary incontinence will be measured using the ICIQ-UI-SF questionnaire, with a dichotomous interpretation of the score: 0 = continent, ≥1 = incontinent.
Measured: Week 1, 7, 13, 19, 25, 31
Effects of the intervention on athletes' knowledge of the pelvic-perineal region
A questionnaire we have developed will measure the effects of the intervention on athletes' knowledge of the pelvic and perineal region. It will consist of 10 questions. This outcome will be assessed by comparing the mean number of correct answers (on a scale of 0 to 10) within and between groups.
Measured: Week 1, 31
The program's effects on associated pelvic and perineal symptoms
The ODS-S questionnaires measure associated pelvic and perineal symptoms. This criterion will be assessed by comparing the mean total scores (on a scale of 0 to 20) within and between groups.
Measured: Week 1, 31
The program's effects on urinary dysfunction.
Section C of the LURN-SI29 questionnaire, which assesses urinary dysfunction. This criterion will be evaluated by comparing the mean total scores (on a scale of 0 to 20) within and between groups.
Measured: Week 1, 31
Number of educational contents viewed
Measured by tracking content views at the end of the session.
Measured: Week 13, 19, 25
Practicing lower back, pelvic, and abdominal stability exercises
Measured by collecting the frequency of implementation.
Measured: Week 1, 7, 13, 19, 25, 31
The dose-response effect related to adherence
Assessed by measuring the effects on the ICIQ-UI-SF score based on the frequency of exercise implementation. Scores typically range from 0 to 21. The higher the score, the more severe the urinary incontinence.
Measured: Week 1, 7, 13, 19, 25, 31
Program satisfaction
Assessed using a questionnaire. This criterion will be expressed as the average of the total scores for the satisfaction and recommendation questions (on a scale of 0 to 10). A score of "10" indicates high satisfaction and a strong recommendation.
Measured: Week 31
Trends in Top Athletic Performance
Measured by the best performance (time/distance) in the most common track and field event.
Time is measured in seconds and minutes. Distance is measured in meters.
Measured: Week 1, 7, 13, 19, 25, 31
Number of educational contents viewed by coaches
Measured by tracking content views at the end of the session
Measured: Week 13, 19, 25
Coaches' level of knowledge regarding the pelvic-perineal region
Assessed using a 10-question questionnaire. This criterion will be expressed through an intra-group and inter-group comparison of the average number of correct answers (on a scale of 0 to 10).
Measured: Week 1, 31
Practicing lumbar-pelvic-abdominal stability exercises
Measured by collecting the frequency as specified in a questionnaire
Measured: Week 1, 7, 13, 19, 25, 31
Coaches' satisfaction with the program
Assessed using a questionnaire. This criterion will be expressed as the average of the total scores for the satisfaction and recommendation questions (on a scale of 0 to 10). A score of "10" indicates high satisfaction and a strong recommendation.
Measured: Week 31
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2026
- Study start17 Sep 2026
- Primary completionJun 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary IncontinenceStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de Saint EtienneThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- A stepped-wedge randomized controlled trial using closed cohort sampling
- Masking
- None (open label)
- Enrolment
- 198 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Pascal EDOUARD, PHD, Principal investigator, CHU de Saint-Etienne
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07644273
- Sponsor's protocol ID
- 26CH163
- Other IDs
- ANSM
- Acronym
- PELVICATHLE
- Status last verified
- Sep 2026
- First submitted
- 2 Jun 2026
- Last updated
- 30 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of a Multimodal and Multidimensional Intervention on Urinary Incontinence in Young Nulliparous Female Athletes. Single-Center Randomized Controlled Stepped-Wedge Trial
- ClinicalTrials.gov ID
- NCT07644273
- Acronym / sponsor ID
- PELVICATHLE / 26CH163
- Conditions
- Urinary Incontinence
- Keywords
- Urinary incontinence, women's health, track and field
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 198 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de Saint EtienneUniversity, hospital or other
- Study start
- 17 Sep 2026 (actual)
- Primary completion
- Jun 2027 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 12 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A prevalence of urinary incontinence ranging from 5.7% to 80% has been observed in young nulliparous athletes during their activity.
The usual recommendations for managing adult women do not seem to be transferable.
Young nulliparous athletes need specific educational and behavioral interventions and an alternative to pelvic floor muscle strengthening.
A multimodal and multidimensional intervention for athletes and coaches combining specific pelvic health education and strengthening of lumbopelvic-abdominal stability appears to be an innovative and optimal solution for reducing the symptoms of urinary incontinence in young nulliparous women who participate in athletics.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- A stepped-wedge randomized controlled trial using closed cohort sampling
| Arm | Type | Receives |
|---|---|---|
| Control condition | Active comparator | Other: Usual activitiesUsual activities |
| Interventional condition | Experimental | Other: Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme.Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening program. |
Who may qualify
- Ages
- 15 to 40 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (7 listed)
- Female subject, nulliparous
- Member of an athletics club affiliated with the French Athletics Federation (FFA)
- At least 15 years old at the start of the study and belonging to the U16/U18/U20/U23 categories (born between January 1, 2005, and September 1, 2011)
- Having internet access
- Having access to a digital device (computer, tablet, mobile phone)
Key exclusion criteria (4 listed)
- Any individual deprived of their liberty or subject to legal protection (guardianship, curatorship, or protective supervision).
- A pregnant woman, a woman who has been pregnant, or a woman planning a pregnancy within the last nine months.
- Any individual unable to understand the purpose and conditions of the study.
- Any individual unable to give their consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme.The intervention will consist of participants: i) reviewing educational content (8 educational videos online) ii) participating in two in-person sessions at the athletics club and performing lumbar-pelvic-abdominal stability exercises iii) learning and implementing recommendations for empowering themselves in pelvic health management. iv) complete reports in 6 questionnaires during follow-up. | Other | Interventional condition |
| Usual activitiesCollection of data on routine activities | Other | Control condition |
Primary outcome
Urinary incontinence symptoms
Time frame: Week 1, 7, 13, 19, 25, 31
Severity of urinary incontinence symptoms as measured by the ICIQ-UI-SF score (International Consultation on Incontinence Questionnaire - Short Form for Urinary Incontinence). Scores typically range from 0 to 21. The higher the score, the more severe the urinary incontinence.
13 secondary outcomes
The program's effects on the prevalence of urinary incontinence
Time frame: Week 1, 7, 13, 19, 25, 31
Effects of the intervention on athletes' knowledge of the pelvic-perineal region
Time frame: Week 1, 31
The program's effects on associated pelvic and perineal symptoms
Time frame: Week 1, 31
The program's effects on urinary dysfunction.
Time frame: Week 1, 31
Number of educational contents viewed
Time frame: Week 13, 19, 25
Practicing lower back, pelvic, and abdominal stability exercises
Time frame: Week 1, 7, 13, 19, 25, 31
The dose-response effect related to adherence
Time frame: Week 1, 7, 13, 19, 25, 31
Program satisfaction
Time frame: Week 31
Trends in Top Athletic Performance
Time frame: Week 1, 7, 13, 19, 25, 31
Number of educational contents viewed by coaches
Time frame: Week 13, 19, 25
Coaches' level of knowledge regarding the pelvic-perineal region
Time frame: Week 1, 31
Practicing lumbar-pelvic-abdominal stability exercises
Time frame: Week 1, 7, 13, 19, 25, 31
Coaches' satisfaction with the program
Time frame: Week 31
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2026.
Related trials for Urinary Incontinence
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Active, not recruitingPhase 2/3
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Urinary Incontinence, Overactive Bladder Syndrome
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Recruiting
UCon Treatment of Overactive Bladder (OAB) in Males
Urinary Incontinence, Urge Incontinence
Active, not recruitingObservational study
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Pascal EDOUARD, PHD principal investigator
CHU de Saint-Etienne
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme. and Usual activities in people with Urinary Incontinence, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Pascal EDOUARD, PHD ((0)477127985 ext. +33, pascal.edouard@univ-st-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Urinary incontinence symptoms (time frame: Week 1, 7, 13, 19, 25, 31). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.